Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?

被引：0
|
作者：
Lee, Yong-ho [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Div Endocrinol & Metab,Dept Internal Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2015年 / 39卷 / 03期
关键词：
SITAGLIPTIN; RISK; DESIGN; TRIAL;
D O I：
10.4093/dmj.2015.39.3.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [31] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Papagianni, M.
    Tziomalos, K.
    HIPPOKRATIA, 2015, 19 (03) : 195 - 199
  • [32] Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
    Richard, Kathleen R.
    Shelburne, Jamie S.
    Kirk, Julienne K.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1609 - 1629
  • [33] Pharmacology of Dipeptidyl Peptidase-4 InhibitorsSimilarities and Differences
    Roberta Baetta
    Alberto Corsini
    Drugs, 2011, 71 : 1441 - 1467
  • [34] Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
    Ametov, A. S.
    Kamynina, L. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (01) : 98 - 102
  • [35] Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension
    Mistry, Goutam C.
    Maes, Andrea L.
    Lasseter, Kenneth C.
    Davies, Michael J.
    Gottesdiener, Keith M.
    Wagner, John A.
    Herman, Gary A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (05): : 592 - 598
  • [36] C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
    Demir, Sevin
    Temizkan, Sule
    Sargin, Mehmet
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [37] Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients
    Li, S. -Y.
    Chen, H. -H.
    Lai, C. -C.
    Lin, C. -L.
    Kao, C. -H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (03) : 181 - 185
  • [38] Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database
    Nagel, Angela K.
    Ahmed-Sarwar, Nabila
    Werner, Paul M.
    Cipriano, Gabriela C.
    Van Manen, Robbert P.
    Brown, Jack E.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (01) : 27 - 31
  • [39] Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
    Terawaki, Yuichi
    Nomiyama, Takashi
    Kawanami, Takako
    Hamaguchi, Yuriko
    Takahashi, Hiroyuki
    Tanaka, Tomoko
    Murase, Kunitaka
    Nagaishi, Ryoko
    Tanabe, Makito
    Yanase, Toshihiko
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [40] Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor
    Takahara, Yusuke
    Tokunou, Tomotake
    Ichiki, Toshihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 698 - 708
12345